These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 28555633)
1. Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease. Bugianesi E; Bizzarri C; Rosso C; Mosca A; Panera N; Veraldi S; Dotta A; Giannone G; Raponi M; Cappa M; Alisi A; Nobili V Am J Gastroenterol; 2017 Aug; 112(8):1277-1286. PubMed ID: 28555633 [TBL] [Abstract][Full Text] [Related]
2. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Wang CW; Lin HY; Shin SJ; Yu ML; Lin ZY; Dai CY; Huang JF; Chen SC; Li SS; Chuang WL Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282 [TBL] [Abstract][Full Text] [Related]
5. Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China. Xu M; Li Y; Zhang S; Wang X; Shen J; Zhang S Ann Hepatol; 2019; 18(3):456-460. PubMed ID: 31054977 [TBL] [Abstract][Full Text] [Related]
6. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682 [TBL] [Abstract][Full Text] [Related]
7. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease. Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529 [TBL] [Abstract][Full Text] [Related]
8. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease. Liu WY; Zheng KI; Pan XY; Ma HL; Zhu PW; Wu XX; Rios RS; Targher G; Byrne CD; Wang XD; Chen YP; Zheng MH J Gastroenterol Hepatol; 2020 Jun; 35(6):1057-1064. PubMed ID: 31677195 [TBL] [Abstract][Full Text] [Related]
9. PNPLA3 gene polymorphism is associated with liver steatosis in children with Down syndrome. Valentini D; Mosca A; Di Camillo C; Crudele A; Sartorelli MR; Scoppola V; Tarani L; Villani A; Raponi M; Novelli A; Alisi A Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1564-1572. PubMed ID: 32636123 [TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants. Del Ben M; Polimeni L; Brancorsini M; Di Costanzo A; D'Erasmo L; Baratta F; Loffredo L; Pastori D; Pignatelli P; Violi F; Arca M; Angelico F Eur J Intern Med; 2014 Jul; 25(6):566-70. PubMed ID: 24947770 [TBL] [Abstract][Full Text] [Related]
11. I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease. Park JH; Cho B; Kwon H; Prilutsky D; Yun JM; Choi HC; Hwang KB; Lee IH; Kim JI; Kong SW Liver Int; 2015 Dec; 35(12):2537-46. PubMed ID: 26148225 [TBL] [Abstract][Full Text] [Related]
13. Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents. Mosca A; Fintini D; Scorletti E; Cappa M; Paone L; Zicari AM; Nobili V; Byrne CD Liver Int; 2018 Dec; 38(12):2301-2308. PubMed ID: 30176114 [TBL] [Abstract][Full Text] [Related]
14. PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress. Carpino G; Pastori D; Baratta F; Overi D; Labbadia G; Polimeni L; Di Costanzo A; Pannitteri G; Carnevale R; Del Ben M; Arca M; Violi F; Angelico F; Gaudio E Sci Rep; 2017 Nov; 7(1):15756. PubMed ID: 29150621 [TBL] [Abstract][Full Text] [Related]
15. TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism. Coppola N; Rosa Z; Cirillo G; Stanzione M; Macera M; Boemio A; Grandone A; Pisaturo M; Marrone A; Adinolfi LE; Sagnelli E; Miraglia del Giudice E Liver Int; 2015 Aug; 35(8):1959-63. PubMed ID: 25581573 [TBL] [Abstract][Full Text] [Related]
16. Study of Family Clustering and PNPLA3 Gene Polymorphism in Pediatric Non Alcoholic Fatty Liver Disease. Sood V; Khanna R; Rawat D; Sharma S; Alam S; Sarin SK Indian Pediatr; 2018 Jul; 55(7):561-567. PubMed ID: 30129536 [TBL] [Abstract][Full Text] [Related]
17. Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children. Lee KJ; Moon JS; Kim NY; Ko JS Pediatr Obes; 2022 Feb; 17(2):e12852. PubMed ID: 34490745 [TBL] [Abstract][Full Text] [Related]
18. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population. Narayanasamy K; Karthick R; Panneerselvam P; Mohan N; Ramachandran A; Prakash R; Rajaram M J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251 [TBL] [Abstract][Full Text] [Related]
19. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B. Viganò M; Valenti L; Lampertico P; Facchetti F; Motta BM; D'Ambrosio R; Romagnoli S; Dongiovanni P; Donati B; Fargion S; Colombo M Hepatology; 2013 Oct; 58(4):1245-52. PubMed ID: 23564580 [TBL] [Abstract][Full Text] [Related]